agilon health, inc. Announces 1-for-25 Reverse Stock Split: Key Details for Investors
On March 18, 2026, agilon health, inc. (NYSE: AGL) issued a significant announcement regarding a reverse stock split of its common stock, a decision with direct implications for shareholders and the company’s trading status.
Key Points of the Reverse Stock Split
- Reverse Stock Split Ratio: agilon health will implement a 1-for-25 reverse stock split. This means every twenty-five shares of the company’s issued and outstanding common stock will be combined into one share.
- Effective Date: The split will become effective on March 30, 2026, at approximately 5:01 p.m. Eastern Time. Trading on a split-adjusted basis will begin on March 31, 2026, under the same ticker symbol, “AGL”.
- Stockholder Approval: The split ratio (ranging from 1-for-5 to 1-for-25) was approved at a Special Meeting held on March 17, 2026, with the board later confirming the 1-for-25 ratio.
- Purpose: The split is designed to increase the price of the company’s common stock above \$1.00 per share, ensuring compliance with NYSE’s minimum bid price requirement for continued listing. Management also aims to improve marketability, liquidity, and broaden investor interest.
- Post-Split Share Count: Following the Effective Time, approximately 16,605,993 shares of common stock will be outstanding.
- No Fractional Shares: Fractional shares will not be issued. Shareholders entitled to fractional shares will receive cash in lieu.
- Adjustments to Equity Incentive Plans: Proportional adjustments will be made to the number of shares available and awarded under the company’s equity incentive plans, and to the exercise price and share counts for options and other securities.
- Transfer Agent: Computershare Inc. will act as the exchange agent. Registered shareholders holding shares electronically do not need to take action. Those with shares in brokerage accounts will have their positions automatically adjusted, subject to broker-specific processes.
- New CUSIP Number: The new CUSIP for agilon’s common stock will be 00857U 206.
Important Information for Shareholders
- Compliance with NYSE Listing Requirements: The reverse split is primarily intended to maintain compliance with the NYSE’s minimum bid price rule, a critical factor for the company’s continued trading status.
- Potential Impact on Share Price: Reverse stock splits are generally implemented to increase the per-share price, which may affect liquidity and investor perception. While this may improve marketability, it can also signal challenges, such as maintaining exchange listing or underlying business issues (e.g., history of net losses).
- No Action Required for Most Holders: Both registered and brokerage account shareholders do not need to take action; shares will be automatically adjusted.
- Equity Incentive Plan Adjustments: Employees and holders of stock options or other securities will see proportional changes in their awards and exercise prices.
- Cash Payment for Fractional Shares: Shareholders receiving less than one share post-split will get cash instead of fractional shares, potentially affecting small investors.
Risks and Forward-Looking Statements
- Compliance Uncertainty: While the reverse split is intended to help regain compliance, there is no guarantee that the company will meet all NYSE standards post-split.
- Business Risks: The company faces numerous risks, including ongoing net losses, challenges in expanding to new markets, securing favorable contracts with payors, dependency on Medicare Advantage payors, ability to recover startup costs, and economic and regulatory uncertainties.
- Operational and Market Risks: Risks include the accuracy of medical expense forecasting, physician partner recruitment, cybersecurity threats, competition, government program changes, and volatility in stock price, among others.
- Leadership Transition: The company is searching for a permanent CEO and acknowledges risks related to management changes and performance initiatives.
Company Background and Outlook
agilon health partners with physician groups and health systems to transition to a value-based care model, especially for senior patients. Its platform supports approximately 2,300 primary care physicians across 30 communities, aiming for a healthcare system focused on value rather than volume. The company continues to grow its partnerships and invest in technology, people, and processes to empower independent physician practices.
Investor Contacts
Media Contact
Conclusion
The announcement of a 1-for-25 reverse stock split is a material event for agilon health, inc. shareholders. It is intended to support continued NYSE listing and may affect share price, liquidity, and investor perception. The company faces ongoing risks related to its business model, market conditions, and leadership transitions. Investors should monitor developments closely and review all SEC filings for more details.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. The information is based on company filings and public disclosures as of March 18, 2026. Investors should conduct their own due diligence and consult with financial advisors prior to making any investment decisions. The company faces risks that may affect its future performance, and past results are not indicative of future outcomes.
View agilon health, inc. Historical chart here
